BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34537236)

  • 1. FTO Suppresses STAT3 Activation and Modulates Proinflammatory Interferon-Stimulated Gene Expression.
    McFadden MJ; Sacco MT; Murphy KA; Park M; Gokhale NS; Somfleth KY; Horner SM
    J Mol Biol; 2022 Mar; 434(6):167247. PubMed ID: 34537236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.
    Sun Z; Sun X; Qin G; Li Y; Zhou G; Jiang X
    Epigenetics; 2023 Dec; 18(1):2242688. PubMed ID: 37538000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.
    Wang Y; Cheng Z; Xu J; Lai M; Liu L; Zuo M; Dang L
    Bioengineered; 2021 Dec; 12(1):1874-1889. PubMed ID: 34076564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mRNA Cap 2'-
    Williams GD; Gokhale NS; Snider DL; Horner SM
    mSphere; 2020 May; 5(3):. PubMed ID: 32404510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
    Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
    Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical Inhibitors Targeting the Oncogenic m
    Huang Y; Xia W; Dong Z; Yang CG
    Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
    Yang Y; Shen F; Huang W; Qin S; Huang JT; Sergi C; Yuan BF; Liu SM
    J Clin Endocrinol Metab; 2019 Mar; 104(3):665-673. PubMed ID: 30137347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NADP modulates RNA m
    Wang L; Song C; Wang N; Li S; Liu Q; Sun Z; Wang K; Yu SC; Yang Q
    Nat Chem Biol; 2020 Dec; 16(12):1394-1402. PubMed ID: 32719557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Takemoto S; Nakano M; Fukami T; Nakajima M
    Biochem Pharmacol; 2021 Nov; 193():114766. PubMed ID: 34536357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of the resistance of human oral epithelial cells to herpes simplex virus type I infection via N6-methyladenosine modification.
    Xu J; Qi Y; Ju Q
    BMC Oral Health; 2023 Feb; 23(1):121. PubMed ID: 36814204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m
    Wu R; Guo G; Bi Z; Liu Y; Zhao Y; Chen N; Wang F; Wang Y; Wang X
    Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):796-806. PubMed ID: 31295563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
    Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
    Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
    Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lncRNA from the FTO locus acts as a suppressor of the m
    Zhang J; Wei J; Sun R; Sheng H; Yin K; Pan Y; Jimenez R; Chen S; Cui XL; Zou Z; Yue Z; Emch MJ; Hawse JR; Wang L; He HH; Xia S; Han B; He C; Huang H
    Mol Cell; 2023 Aug; 83(15):2692-2708.e7. PubMed ID: 37478845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTO contributes to hepatic metabolism regulation through regulation of leptin action and STAT3 signalling in liver.
    Bravard A; Vial G; Chauvin MA; Rouillé Y; Bailleul B; Vidal H; Rieusset J
    Cell Commun Signal; 2014 Jan; 12():4. PubMed ID: 24410832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m
    Zhou P; Wu M; Ye C; Xu Q; Wang L
    J Biol Chem; 2019 Nov; 294(45):16908-16917. PubMed ID: 31578283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transcriptional regulation of antiviral gene expression by N6-methyladenosine.
    McFadden MJ; McIntyre ABR; Mourelatos H; Abell NS; Gokhale NS; Ipas H; Xhemalçe B; Mason CE; Horner SM
    Cell Rep; 2021 Mar; 34(9):108798. PubMed ID: 33657363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells.
    Relier S; Rivals E; David A
    RNA Biol; 2022; 19(1):132-142. PubMed ID: 35067178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
    Zhang X; Hao H; Ma L; Zhang Y; Hu X; Chen Z; Liu D; Yuan J; Hu Z; Guan W
    mBio; 2021 Aug; 12(4):e0106721. PubMed ID: 34225491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.